Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
Wally V, Hovnanian A, Ly J, Buckova H, Brunner V, Lettner T, Ablinger M, Felder TK, Hofbauer P, Wolkersdorfer M, Lagler FB, Hitzl W, Laimer M, Kitzmüller S, Diem A, Bauer JW. Wally V, et al. Among authors: hofbauer p. J Am Acad Dermatol. 2018 May;78(5):892-901.e7. doi: 10.1016/j.jaad.2018.01.019. Epub 2018 Feb 2. J Am Acad Dermatol. 2018. PMID: 29410318 Free article. Clinical Trial.
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study.
Wally V, Kitzmueller S, Lagler F, Moder A, Hitzl W, Wolkersdorfer M, Hofbauer P, Felder TK, Dornauer M, Diem A, Eiler N, Bauer JW. Wally V, et al. Among authors: hofbauer p. Orphanet J Rare Dis. 2013 May 7;8:69. doi: 10.1186/1750-1172-8-69. Orphanet J Rare Dis. 2013. PMID: 23651789 Free PMC article. Clinical Trial.
Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
Ablinger M, Felder TK, Wimmer M, Zauner R, Hofbauer P, Lettner T, Wolkersdorfer M, Lagler FB, Diem A, Bauer JW, Wally V. Ablinger M, et al. Among authors: hofbauer p. Orphanet J Rare Dis. 2018 Nov 1;13(1):193. doi: 10.1186/s13023-018-0940-1. Orphanet J Rare Dis. 2018. PMID: 30382914 Free PMC article. Clinical Trial.
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial.
Guttmann-Gruber C, Piñón Hofbauer J, Tockner B, Reichl V, Klausegger A, Hofbauer P, Wolkersdorfer M, Tham KC, Lim SS, Common JE, Diem A, Ude-Schoder K, Hitzl W, Lagler F, Reichelt J, Bauer JW, Lang R, Laimer M. Guttmann-Gruber C, et al. Among authors: hofbauer p. Orphanet J Rare Dis. 2021 Nov 8;16(1):473. doi: 10.1186/s13023-021-02062-2. Orphanet J Rare Dis. 2021. PMID: 34749770 Free PMC article. Clinical Trial.
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Guttmann-Gruber C, Tockner B, Scharler C, Hüttner C, Common JE, Tay ASL, Denil SLIJ, Klausegger A, Trost A, Breitenbach J, Schnitzhofer P, Hofbauer P, Wolkersdorfer M, Diem A, Laimer M, Strunk D, Bauer JW, Reichelt J, Lang R, Piñón Hofbauer J. Guttmann-Gruber C, et al. Among authors: hofbauer p. Sci Rep. 2018 Sep 7;8(1):13430. doi: 10.1038/s41598-018-31823-6. Sci Rep. 2018. PMID: 30194425 Free PMC article.
Efficacy and safety of roflumilast in the treatment of asthma.
Bateman ED, Izquierdo JL, Harnest U, Hofbauer P, Magyar P, Schmid-Wirlitsch C, Leichtl S, Bredenbröker D. Bateman ED, et al. Among authors: hofbauer p. Ann Allergy Asthma Immunol. 2006 May;96(5):679-86. doi: 10.1016/S1081-1206(10)61065-4. Ann Allergy Asthma Immunol. 2006. PMID: 16729780 Clinical Trial.
32 results